<article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         dtd-version="1.0"
         article-type="research-article">
   <front>
      <journal-meta>
         <journal-id journal-id-type="jstor">intejhealcarefin</journal-id>
         <journal-id journal-id-type="jstor">j100925</journal-id>
         <journal-title-group>
            <journal-title>International Journal of Health Care Finance and Economics</journal-title>
         </journal-title-group>
         <publisher>
            <publisher-name>Kluwer Academic Publishers</publisher-name>
         </publisher>
         <issn pub-type="ppub">13896563</issn>
         <issn pub-type="epub">15736962</issn>
         <custom-meta-group/>
      </journal-meta>
      <article-meta>
         <article-id pub-id-type="jstor">25067714</article-id>
         <title-group>
            <article-title>The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982-2001</article-title>
         </title-group>
         <contrib-group>
            <contrib>
               <string-name>
                  <given-names>Frank R.</given-names>
                  <surname>Lichtenberg</surname>
               </string-name>
            </contrib>
         </contrib-group>
         <pub-date>
            <day>1</day>
            <month>3</month>
            <year>2005</year>
         </pub-date>
         <volume xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">5</volume>
         <issue xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">1</issue>
         <issue-id>i25067709</issue-id>
         <fpage>47</fpage>
         <lpage>73</lpage>
         <permissions>
            <copyright-statement>Copyright 2005 Springer Science + Business Media, Inc.</copyright-statement>
         </permissions>
         <self-uri xlink:href="https://www.jstor.org/stable/25067714"/>
         <abstract>
            <p>We perform an econometric analysis of the effect of new drug launches on longevity, using data from the IMS Health Drug Launches database and the WHO Mortality Database. Under conservative assumptions, our estimates imply that the average annual increase in life expectancy of the entire population resulting from new drug launches is about one week, and that the incremental cost effectiveness ratio (new drug expenditure per person per year divided by the increase in life-years per person per year attributable to new drug launches) is about $6750-far lower than most estimates of the value of a statistical life-year.</p>
         </abstract>
         <kwd-group>
            <kwd>Life expectancy</kwd>
            <kwd>Longevity</kwd>
            <kwd>Mortality</kwd>
            <kwd>Pharmaceuticals</kwd>
            <kwd>Innovation</kwd>
            <kwd>Cost-effectiveness</kwd>
            <kwd>I12</kwd>
            <kwd>O33</kwd>
            <kwd>O40</kwd>
         </kwd-group>
         <custom-meta-group>
            <custom-meta>
               <meta-name>lang</meta-name>
               <meta-value>eng</meta-value>
            </custom-meta>
         </custom-meta-group>
      </article-meta>
   </front>
   <back>
      <ref-list>
         <title>Notes</title>
         <ref id="d36e264a1310">
            <label>1</label>
            <mixed-citation id="d36e271" publication-type="other">
Nordhaus (2002:17)</mixed-citation>
         </ref>
         <ref id="d36e278a1310">
            <label>2</label>
            <mixed-citation id="d36e285" publication-type="other">
National Science Board, Science &amp;amp; Engineering Indicators—1996
&amp;amp;lt;http://www.nsf.gov/sbe/srs/seind96/at04-31.xls&amp;amp;gt;;</mixed-citation>
            <mixed-citation id="d36e294" publication-type="other">
National Science Foundation, Research and
Development in Industry: 1994 &amp;amp;lt;http://www.nsf.gov/sbe/srs/nsf97331/tables/nsf94a08.xls&amp;amp;gt;;</mixed-citation>
            <mixed-citation id="d36e303" publication-type="other">
Phar-
maceutical Research and Manufacturers of America, Pharmaceutical Industry Profile 2004 (Washington, DC:
PhRMA, 2004&amp;amp;lt;http://www.phrma.Org/publications/publications//2004-03-31.937.pdf&amp;amp;gt;.</mixed-citation>
         </ref>
         <ref id="d36e316a1310">
            <label>4</label>
            <mixed-citation id="d36e323" publication-type="other">
Romer (1990)</mixed-citation>
         </ref>
         <ref id="d36e330a1310">
            <label>11</label>
            <mixed-citation id="d36e337" publication-type="other">
http://www3.who.int/whosis/whsa/ftp/download.htm</mixed-citation>
         </ref>
         <ref id="d36e345a1310">
            <label>18</label>
            <mixed-citation id="d36e352" publication-type="other">
Berndt, Kyle and Ling (2003)</mixed-citation>
         </ref>
         <ref id="d36e359a1310">
            <label>24</label>
            <mixed-citation id="d36e366" publication-type="other">
Simon et al.
1999</mixed-citation>
            <mixed-citation id="d36e375" publication-type="other">
Liu
et al. (1997)</mixed-citation>
         </ref>
      </ref-list>
      <ref-list>
         <title>References</title>
         <ref id="d36e394a1310">
            <mixed-citation id="d36e398" publication-type="other">
Agency for Healthcare Research and Quality (2002). "MEPS H38 Codebook: 1999 Full Year Consolidated Data
File Codebook." November 27, http://www.meps.ahrq.gov/Pubdoc/HC038/H38CB.pdf</mixed-citation>
         </ref>
         <ref id="d36e408a1310">
            <mixed-citation id="d36e412" publication-type="other">
Arias, E. (2002). "United States Life Tables, 2000." National Vital Statistics Reports 51(3). (Hyattsville, MD:
National Center for Health Statistics).</mixed-citation>
         </ref>
         <ref id="d36e422a1310">
            <mixed-citation id="d36e426" publication-type="other">
Berndt, Ernst, Margaret K. Kyle, and Davina Ling. (2003). "The Long Shadow of Patent Expiration: Do Rx to
OTC Switches Provide an Afterlife?" In Robert C. Feenstra and Matthew D. Shapiro (eds.), Scanner Data and
Price Indexes, Chicago: University of Chicago Press.</mixed-citation>
         </ref>
         <ref id="d36e439a1310">
            <mixed-citation id="d36e443" publication-type="other">
Bresnahan, T. and R. Gordon. (1997). The Economics of New Goods. Chicago: University of Chicago Press.</mixed-citation>
         </ref>
         <ref id="d36e451a1310">
            <mixed-citation id="d36e455" publication-type="other">
Cutler, D. and M. McClellan. (2001). "Is Technological Change in Medicine Worth It?" Health Affairs 20(5),
11-29.</mixed-citation>
         </ref>
         <ref id="d36e465a1310">
            <mixed-citation id="d36e469" publication-type="other">
Danzon, P., Y. R. Wang, and L. Wang. (2003). "The Impact of Price Regulation on the Launch Delay of
New Drugs—A Study of Twenty-Five Major Markets in the 1990s." http://hc.wharton.upenn.edu/danzon/PDF
Files/LaunchDelayPaper.pdf.</mixed-citation>
         </ref>
         <ref id="d36e482a1310">
            <mixed-citation id="d36e486" publication-type="other">
Folland, S., A. Goodman, and M. Stano. (2001). The Economics of Health and Health Care, third edition. Upper
Saddle River, NJ: Prentice Hall.</mixed-citation>
         </ref>
         <ref id="d36e496a1310">
            <mixed-citation id="d36e500" publication-type="other">
Getzen, T. (1997). Health Economics: Fundamentals and Flow of Funds. New York, NY: John Wiley and Sons.</mixed-citation>
         </ref>
         <ref id="d36e507a1310">
            <mixed-citation id="d36e511" publication-type="other">
Global Forum for Health Research (2002). The 10/90 Report on Health Research 2001-2002. Geneva: Global
Forum for Health Research. ISBN 2-940286-07-8. http://www.globalforumhealth.org/pages/index.asp</mixed-citation>
         </ref>
         <ref id="d36e521a1310">
            <mixed-citation id="d36e525" publication-type="other">
Grier, Holcombe et al. (2003). "Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's
Sarcoma and Primitive Neuroectodermal Tumor of Bone." New England Journal of Medicine 348(8), 694-701.</mixed-citation>
         </ref>
         <ref id="d36e536a1310">
            <mixed-citation id="d36e540" publication-type="other">
Henderson, J. (1999). Health Economics and Policy. Cincinnati, OH: South-Western Publishing Co.</mixed-citation>
         </ref>
         <ref id="d36e547a1310">
            <mixed-citation id="d36e551" publication-type="other">
IMS Health, http://www.ims-global.com/.</mixed-citation>
         </ref>
         <ref id="d36e558a1310">
            <mixed-citation id="d36e562" publication-type="other">
Kyle, M. K. (2003). "Product Entry in Global Pharmaceutical Markets: A Cross-National Study." Unpublished
paper, Carnegie-Mellon University.</mixed-citation>
         </ref>
         <ref id="d36e572a1310">
            <mixed-citation id="d36e576" publication-type="other">
Lichtenberg, F. (1996). "Do (More and Better) Drugs Keep People Out of Hospitals?" American Economic Review
86, 384-388.</mixed-citation>
         </ref>
         <ref id="d36e586a1310">
            <mixed-citation id="d36e590" publication-type="other">
Lichtenberg, F (2001). "Are the Benefits of Newer Drugs Worth Their Cost? Evidence from the 1996 MEPS."
Health Affairs 20(5), 241-251.</mixed-citation>
         </ref>
         <ref id="d36e600a1310">
            <mixed-citation id="d36e604" publication-type="other">
Liu, Jin-Tan, James K. Hammitt, and Jin-Long Liu (1997). "Estimated Hedonic Wage Function and the Value of
Life in a Developing Country." Economics Letters 57, 353-358.</mixed-citation>
         </ref>
         <ref id="d36e615a1310">
            <mixed-citation id="d36e619" publication-type="other">
Murphy, K. M. and R. H. Topel. (2003). "The Economic Value of Medical Research." In Kevin M. Murphy
and Robert H. Topel (eds.), Measuring the Gains from Medical Research: An Economic Approach. Chicago:
University of Chicago Press.</mixed-citation>
         </ref>
         <ref id="d36e632a1310">
            <mixed-citation id="d36e636" publication-type="other">
Nordhaus, W. (2003). "The Health of Nations: The Contribution of Improved Health to Living Standards." In
Kevin M. Murphy and Robert H. Topel (eds.), Measuring the Gains from Medical Research: An Economic
Approach. Chicago: University of Chicago Press.</mixed-citation>
         </ref>
         <ref id="d36e649a1310">
            <mixed-citation id="d36e653" publication-type="other">
OECD Health Database, http://www.credes.fr/english/ecosante/oecd.htm.</mixed-citation>
         </ref>
         <ref id="d36e660a1310">
            <mixed-citation id="d36e664" publication-type="other">
Romer, Paul (1990). "Endogenous Technical Change." Journal of Political Economy 98, S71-S102.</mixed-citation>
         </ref>
         <ref id="d36e671a1310">
            <mixed-citation id="d36e675" publication-type="other">
Santerre, R. and S. Neun. (2000). Health Economics: Theories, Insights, and Industry Studies, revised edition.
Orlando, FL: Dryden Press.</mixed-citation>
         </ref>
         <ref id="d36e685a1310">
            <mixed-citation id="d36e689" publication-type="other">
Simon, N. B., M. L. Cropper, A. Alberini, and S. Arora. (1999). "Valuing Mortality Reductions in India: A Study
of Compensating-Wage Differentials." World Bank Working Paper Series #2078, March.</mixed-citation>
         </ref>
         <ref id="d36e700a1310">
            <mixed-citation id="d36e704" publication-type="other">
Stenestrand, U. et al. (2001). "Early Statin Treatment Following Acute Myocardial Infarction and 1-year Survival,"
Journal of the American Medical Association 285(4), 430-436.</mixed-citation>
         </ref>
         <ref id="d36e714a1310">
            <mixed-citation id="d36e718" publication-type="other">
United Nations, World Population Prospects Population Database, http://esa.un.org/unpp/index.asp?panel = 2.</mixed-citation>
         </ref>
         <ref id="d36e725a1310">
            <mixed-citation id="d36e729" publication-type="other">
U.S. Pharmacist (2002). "Cancer News," Vol. 27(11), posted November 15, http://www.uspharmacist.com/index.
asp?show=article&amp;amp;page = 8_999.htm</mixed-citation>
         </ref>
         <ref id="d36e739a1310">
            <mixed-citation id="d36e743" publication-type="other">
World Health Organization, WHO Mortality Database, http://www3.who.int/whosis/whsa/ftp/download.htm.</mixed-citation>
         </ref>
      </ref-list>
   </back>
</article>
